Clinical Trial Update: Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates a combination of topotecan, vincristine, and doxorubicin in young patients with refractory stage 4 neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Topotecan (topotecan)
• Vincristine (vincristine)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Neuroblastoma | Phase 2 | Status: UNKNOWN